Skip to main content
. 2019 Dec 30;26(2):269–277. doi: 10.1111/hae.13922

Figure 4.

Figure 4

Percentage of patients with an abnormal diagnostic test. A, tests results on screening assays, (B) results on confirmation assays. * Significance between the group reaching a final diagnosis and the B.U.C. group. Significance between the other groups are not shown. ++ Percentages are pertaining the group concerned. † VWD is also part of our screening panel. Moreover, an extended VWF panel is used for confirmation of von Willebrand Disease